| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.43B | 21.49B | 21.45B | 20.97B | 19.78B | 17.25B |
| Gross Profit | 8.88B | 8.12B | 7.54B | 7.50B | 7.06B | 6.83B |
| EBITDA | 2.74B | 2.61B | 2.52B | 2.19B | 1.89B | 1.81B |
| Net Income | 873.15M | 860.53M | 832.58M | 659.84M | 572.41M | 498.73M |
Balance Sheet | ||||||
| Total Assets | 18.75B | 17.60B | 16.23B | 15.06B | 15.17B | 15.11B |
| Cash, Cash Equivalents and Short-Term Investments | 5.06B | 4.02B | 2.55B | 1.11B | 1.68B | 1.90B |
| Total Debt | 78.34M | 85.58M | 79.38M | 57.71M | 77.23M | 110.47M |
| Total Liabilities | 8.60B | 7.40B | 6.54B | 6.20B | 6.78B | 7.03B |
| Stockholders Equity | 6.61B | 6.46B | 6.02B | 5.52B | 5.16B | 4.95B |
Cash Flow | ||||||
| Free Cash Flow | 2.37B | 2.07B | 1.80B | 259.17M | 360.41M | 1.65B |
| Operating Cash Flow | 3.09B | 2.85B | 2.43B | 1.14B | 1.07B | 2.21B |
| Investing Cash Flow | -622.86M | -560.83M | -564.43M | -851.23M | -846.64M | -374.88M |
| Financing Cash Flow | -1.08B | -564.93M | -609.65M | -844.13M | -496.06M | -813.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$10.60B | 12.99 | 12.69% | 3.62% | 10.05% | 9.01% | |
71 Outperform | HK$35.07B | 15.79 | 15.41% | 5.64% | 8.19% | 23.16% | |
64 Neutral | HK$534.88B | 30.61 | 42.43% | 1.73% | 4.14% | 7.35% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | HK$7.57B | 23.14 | 7.42% | 1.41% | 7.29% | -33.19% | |
58 Neutral | HK$6.54B | 13.00 | 7.63% | 2.21% | -3.39% | 91.63% | |
55 Neutral | HK$11.68B | -10.36 | -23.27% | 0.86% | -2.69% | -695.87% |